Unraveling the Impact of Intratumoral Heterogeneity on EGFR Tyrosine Kinase Inhibitor Resistance in EGFR-Mutated NSCLC
Keigo Kobayashi(Osaka Gakuin University), Aaron C. Tan(Baker Heart and Diabetes Institute)
Cited by 19
Related Papers
High Pressure NQR Measurement in CeCu<sub>2</sub>Si<sub>2</sub> up to Sudden Disappearance of Superconductivity
|Journal of the Physical Society of Japan|2008|78
Real-world Efficacy and Safety of Nivolumab for Advanced Non–Small-cell Lung Cancer: A Retrospective Multicenter Analysis
|Clinical Lung Cancer|2018|55
Molecular dynamics simulation-guided drug sensitivity prediction for lung cancer with rare <i>EGFR</i> mutations
|Proceedings of the National Academy of Sciences|2019|54
IGF2 Autocrine-Mediated IGF1R Activation Is a Clinically Relevant Mechanism of Osimertinib Resistance in Lung Cancer
|Molecular Cancer Research|2020|54